The new UK Government Biological Security Strategy explicitly recognized the important role played by IBBIS and the importance of DNA synthesis screening.

Dr. Millett participates in inaugural OECD Global Forum on Technology with more than 300 senior policymakers and leading technology experts to discuss "shaping our future at the tech frontier."

IBBIS Executive Director Piers Millett provided a progress update to the annual meeting of the Biosecurity Innovation and Risk Reduction Initiative.

IBBIS' Executive Director Piers Millett took to the main stage of the 2023 SynBioBeta Global Synthetic Biology Conference.

Millett discusses the need for the international Common Mechanism and why IBBIS is well-positioned to develop this tool for DNA providers.

IBBIS Executive Director Dr. Piers Millett joined global leaders in public health, biotechnology, and international security at NTI's side event at the 2023 Munich Security Conference.

Science | Business International Editor David Matthews explains how IBBIS will work with researchers, funders, and industry stakeholders.

IBBIS was the main feature in a side event during the 9th Review Conference of the Biological Weapons Convention (BWC) in Geneva, Switzerland.

IBBIS Executive Director Dr. Piers Millett attended the 7th annual Global Technology Summit in New Delhi.

Dr. Piers Millett attended the G7 Global Partnership Against the Spread of Weapons and Materials of Mass Destruction Working Group and Conference on Biosecurity Challenges in Berlin, Germany on October 5, 2022.

Margaret Hamburg, Jaime Yassif, Hayley Severance and R. Alta Charo propose the establishment of IBBIS to reduce biosecurity risks.

Plans to establish IBBIS were described in a testimony to a U.S. House Foreign Affairs Subcommittee.